VRDN EBITDA Growth
Viridian Therapeutics Ors Inc · EBITDA Growth
VRDN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-7.91%period ending
VRDN TTM EBITDA YoY % (-13937.11% → -7.91%)
Year-over-year change
High-resolution chart · PNG
VRDN ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -7.913% | |
| -14.5097% | |
| -25.3451% | |
| -17.9853% | |
| -51.531% | |
| -41.5562% | |
| -13.1702% | |
| -17.8161% | |
| -14.1923% | |
| -25.6377% | |
| -82.4068% | |
| -91.3238% | |
| -101.3626% | |
| -98.2978% | |
| -62.6227% | |
| -58.0729% | |
| -56.5314% | |
| -70.1437% | |
| -97.6559% | |
| -159.0551% | |
| -88.8765% | |
| -43.5395% | |
| -3.267% | |
| 32.8572% | |
| 14.3904% | |
| 7.9189% | |
| -23.4612% | |
| -48.2184% | |
| -57.1702% | |
| -64.7672% | |
| -22.1571% | |
| -9.6593% | |
| -15.6424% | |
| -40.6126% | |
| -106.4477% | |
| -149.5239% | |
| -86.5017% | |
| -46.0678% | |
| -11.6028% | |
| 2.2236% | |
| -29.0479% | |
| -23.9697% | |
| -66.3867% | |
| -144.7079% | |
| -205.5721% | |
| -6,581.0309% | |
| -13,937.1059% |